Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.

Luis G Carvajal-Carmona | Tracy A O'Mara | Jodie N Painter | Felicity A Lose | Joe Dennis | Kyriaki Michailidou | Jonathan P Tyrer | Shahana Ahmed | Kaltin Ferguson | Catherine S Healey | Karen Pooley | Jonathan Beesley | Timothy Cheng | Angela Jones | Kimberley Howarth | Lynn Martin | Maggie Gorman | Shirley Hodgson | National Study of Endometrial Cancer Genetics Group (NSECG) | Australian National Endometrial Cancer Study Group (ANECS) | Nicholas Wentzensen | Peter A Fasching | Alexander Hein | Matthias W Beckmann | Stefan P Renner | Thilo Dörk | Peter Hillemanns | Matthias Dürst | Ingo Runnebaum | Diether Lambrechts | Lieve Coenegrachts | Stefanie Schrauwen | Frederic Amant | Boris Winterhoff | Sean C Dowdy | Ellen L Goode | Attila Teoman | Helga B Salvesen | Jone Trovik | Tormund S Njolstad | Henrica M J Werner | Rodney J Scott | Katie Ashton | Tony Proietto | Geoffrey Otton | Ofra Wersäll | Miriam Mints | Emma Tham | RENDOCAS | Per Hall | Kamila Czene | Jianjun Liu | Jingmei Li | John L Hopper | Melissa C Southey | Australian Ovarian Cancer Study (AOCS) | Arif B Ekici | Matthias Ruebner | Nichola Johnson | Julian Peto | Barbara Burwinkel | Frederik Marme | Hermann Brenner | Aida K Dieffenbach | Alfons Meindl | Hiltrud Brauch | GENICA Network | Annika Lindblom | Jeroen Depreeuw | Matthieu Moisse | Jenny Chang-Claude | Anja Rudolph | Fergus J Couch | Janet E Olson | Graham G Giles | Fiona Bruinsma | Julie M Cunningham | Brooke L Fridley | Anne-Lise Børresen-Dale | Vessela N Kristensen | Angela Cox | Anthony J Swerdlow | Nicholas Orr | Manjeet K Bolla | Qin Wang | Rachel Palmieri Weber | Zhihua Chen | Mitul Shah | Paul D P Pharoah | Alison M Dunning | Ian Tomlinson | Douglas F Easton | Amanda B Spurdle | Deborah J Thompson
Human genetics | 2015

Several studies have reported associations between multiple cancer types and single-nucleotide polymorphisms (SNPs) on chromosome 5p15, which harbours TERT and CLPTM1L, but no such association has been reported with endometrial cancer. To evaluate the role of genetic variants at the TERT-CLPTM1L region in endometrial cancer risk, we carried out comprehensive fine-mapping analyses of genotyped and imputed SNPs using a custom Illumina iSelect array which includes dense SNP coverage of this region. We examined 396 SNPs (113 genotyped, 283 imputed) in 4,401 endometrial cancer cases and 28,758 controls. Single-SNP and forward/backward logistic regression models suggested evidence for three variants independently associated with endometrial cancer risk (P = 4.9 × 10(-6) to P = 7.7 × 10(-5)). Only one falls into a haplotype previously associated with other cancer types (rs7705526, in TERT intron 1), and this SNP has been shown to alter TERT promoter activity. One of the novel associations (rs13174814) maps to a second region in the TERT promoter and the other (rs62329728) is in the promoter region of CLPTM1L; neither are correlated with previously reported cancer-associated SNPs. Using TCGA RNASeq data, we found significantly increased expression of both TERT and CLPTM1L in endometrial cancer tissue compared with normal tissue (TERT P = 1.5 × 10(-18), CLPTM1L P = 1.5 × 10(-19)). Our study thus reports a novel endometrial cancer risk locus and expands the spectrum of cancer types associated with genetic variation at 5p15, further highlighting the importance of this region for cancer susceptibility.

Pubmed ID: 25487306 RIS Download

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: P30 AG043097
  • Agency: Wellcome Trust, United Kingdom
    Id: 075491/Z/04
  • Agency: CIHR, Canada
  • Agency: Cancer Research UK, United Kingdom
    Id: C12292/A11174
  • Agency: NCI NIH HHS, United States
    Id: R01 CA128978
  • Agency: NCI NIH HHS, United States
    Id: U19 CA148537
  • Agency: NCI NIH HHS, United States
    Id: R01 CA90899
  • Agency: Cancer Research UK, United Kingdom
    Id: C1287/A12014
  • Agency: NCI NIH HHS, United States
    Id: K12CA138464
  • Agency: NCI NIH HHS, United States
    Id: N01 CA015083
  • Agency: NIA NIH HHS, United States
    Id: P30AG043097
  • Agency: Cancer Research UK, United Kingdom
    Id: 10124
  • Agency: NCI NIH HHS, United States
    Id: R01 CA64277
  • Agency: NCI NIH HHS, United States
    Id: 1U19 CA148065
  • Agency: Cancer Research UK, United Kingdom
    Id: C5047/A10692
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092585
  • Agency: NCI NIH HHS, United States
    Id: 1U19 CA148537
  • Agency: NCI NIH HHS, United States
    Id: R01 CA090899
  • Agency: Cancer Research UK, United Kingdom
    Id: C490/A10124
  • Agency: Cancer Research UK, United Kingdom
    Id: C5047/A8384
  • Agency: Cancer Research UK, United Kingdom
    Id: C1287/A 10710
  • Agency: NCI NIH HHS, United States
    Id: R01 CA064277
  • Agency: NCI NIH HHS, United States
    Id: K12 CA138464
  • Agency: NCI NIH HHS, United States
    Id: R01 CA122443
  • Agency: NCI NIH HHS, United States
    Id: P30 CA015083
  • Agency: Cancer Research UK, United Kingdom
    Id: C5047/A15007
  • Agency: NCI NIH HHS, United States
    Id: 1U19 CA148112
  • Agency: NCI NIH HHS, United States
    Id: R01 CA 092585
  • Agency: NCI NIH HHS, United States
    Id: U19 CA148112
  • Agency: NCI NIH HHS, United States
    Id: U19 CA148065
  • Agency: Wellcome Trust, United Kingdom
  • Agency: NCI NIH HHS, United States
    Id: P30 CA15083
  • Agency: Cancer Research UK, United Kingdom
    Id: C1281/A12014
  • Agency: Cancer Research UK, United Kingdom
    Id: C1287/A10118
  • Agency: NCI NIH HHS, United States
    Id: CA 15083
  • Agency: NCI NIH HHS, United States
    Id: P50 CA136393

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International HapMap Project (tool)

RRID:SCR_002846

THIS RESOURCE IS NO LONGER IN SERVICE, documented August 22, 2016. A multi-country collaboration among scientists and funding agencies to develop a public resource where genetic similarities and differences in human beings are identified and catalogued. Using this information, researchers will be able to find genes that affect health, disease, and individual responses to medications and environmental factors. All of the information generated by the Project will be released into the public domain. Their goal is to compare the genetic sequences of different individuals to identify chromosomal regions where genetic variants are shared. Public and private organizations in six countries are participating in the International HapMap Project. Data generated by the Project can be downloaded with minimal constraints. HapMap project related data, software, and documentation include: bulk data on genotypes, frequencies, LD data, phasing data, allocated SNPs, recombination rates and hotspots, SNP assays, Perlegen amplicons, raw data, inferred genotypes, and mitochondrial and chrY haplogroups; Generic Genome Browser software; protocols and information on assay design, genotyping and other protocols used in the project; and documentation of samples/individuals and the XML format used in the project.

View all literature mentions

Entrez GEO Profiles (tool)

RRID:SCR_004584

The GEO Profiles database stores gene expression profiles derived from curated GEO DataSets. Each Profile is presented as a chart that displays the expression level of one gene across all Samples within a DataSet. Experimental context is provided in the bars along the bottom of the charts making it possible to see at a glance whether a gene is differentially expressed across different experimental conditions. Profiles have various types of links including internal links that connect genes that exhibit similar behaviour, and external links to relevant records in other NCBI databases. GEO Profiles can be searched using many different attributes including keywords, gene symbols, gene names, GenBank accession numbers, or Profiles flagged as being differentially expressed.

View all literature mentions

GLOBOCAN (tool)

RRID:SCR_012750

The aim of the project is to provide contemporary estimates of the incidence of, mortality and prevalence from major types of cancer, at national level, for 184 countries of the world. The GLOBOCAN estimates are presented for 2012, separately for each sex. 1-, 3- and 5-year prevalence data are available for the adult population only (ages 15 and over). Please note that: These estimates are based on the most recent data available at IARC and on information publically available on the Internet, but more recent figures may be available directly from local sources. Because the sources of data are continuously improving in quality and extent, estimates may not be truly comparable overtime and care should be taken when comparing these estimates with those published earlier. The observed differences may be the result of a change in the methodology and should not be interpreted as a time trend effect.

View all literature mentions

Gene Expression Omnibus (GEO) (tool)

RRID:SCR_005012

Functional genomics data repository supporting MIAME-compliant data submissions. Includes microarray-based experiments measuring the abundance of mRNA, genomic DNA, and protein molecules, as well as non-array-based technologies such as serial analysis of gene expression (SAGE) and mass spectrometry proteomic technology. Array- and sequence-based data are accepted. Collection of curated gene expression DataSets, as well as original Series and Platform records. The database can be searched using keywords, organism, DataSet type and authors. DataSet records contain additional resources including cluster tools and differential expression queries.

View all literature mentions

PLINK (tool)

RRID:SCR_001757

Open source whole genome association analysis toolset, designed to perform range of basic, large scale analyses in computationally efficient manner. Used for analysis of genotype/phenotype data. Through integration with gPLINK and Haploview, there is some support for subsequent visualization, annotation and storage of results. PLINK 1.9 is improved and second generation of the software.

View all literature mentions

1000 Genomes Project and AWS (tool)

RRID:SCR_008801

A dataset containing the full genomic sequence of 1,700 individuals, freely available for research use. The 1000 Genomes Project is an international research effort coordinated by a consortium of 75 companies and organizations to establish the most detailed catalogue of human genetic variation. The project has grown to 200 terabytes of genomic data including DNA sequenced from more than 1,700 individuals that researchers can now access on AWS for use in disease research free of charge. The dataset containing the full genomic sequence of 1,700 individuals is now available to all via Amazon S3. The data can be found at: http://s3.amazonaws.com/1000genomes The 1000 Genomes Project aims to include the genomes of more than 2,662 individuals from 26 populations around the world, and the NIH will continue to add the remaining genome samples to the data collection this year. Public Data Sets on AWS provide a centralized repository of public data hosted on Amazon Simple Storage Service (Amazon S3). The data can be seamlessly accessed from AWS services such Amazon Elastic Compute Cloud (Amazon EC2) and Amazon Elastic MapReduce (Amazon EMR), which provide organizations with the highly scalable compute resources needed to take advantage of these large data collections. AWS is storing the public data sets at no charge to the community. Researchers pay only for the additional AWS resources they need for further processing or analysis of the data. All 200 TB of the latest 1000 Genomes Project data is available in a publicly available Amazon S3 bucket. You can access the data via simple HTTP requests, or take advantage of the AWS SDKs in languages such as Ruby, Java, Python, .NET and PHP. Researchers can use the Amazon EC2 utility computing service to dive into this data without the usual capital investment required to work with data at this scale. AWS also provides a number of orchestration and automation services to help teams make their research available to others to remix and reuse. Making the data available via a bucket in Amazon S3 also means that customers can crunch the information using Hadoop via Amazon Elastic MapReduce, and take advantage of the growing collection of tools for running bioinformatics job flows, such as CloudBurst and Crossbow.

View all literature mentions

TAGGER (tool)

RRID:SCR_009419

Software application (entry from Genetic Analysis Software)

View all literature mentions